FAP and Duchenne muscular dystrophy: This suggests that the existence of a population of active proliferative FAPs that could produce higher levels of collagen is key in the process of active muscle degeneration reinforcing the idea that treating patients with drugs inhibiting FAP proliferation or activation could be beneficial for DMD patients [61, 62].